Cargando…
Imatinib in COVID-19: hope and caution
Autores principales: | Bernal-Bello, David, Morales-Ortega, Alejandro, Isabel Farfán-Sedano, Ana, de Tena, Jaime García, Martín-López, Juan Víctor San |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409974/ https://www.ncbi.nlm.nih.gov/pubmed/34147143 http://dx.doi.org/10.1016/S2213-2600(21)00266-6 |
Ejemplares similares
-
Imatinib for COVID-19: A case report
por: Morales-Ortega, Alejandro, et al.
Publicado: (2020) -
Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients
por: Morales-Ortega, Alejandro, et al.
Publicado: (2022) -
Imatinib might constitute a treatment option for lung involvement in COVID-19
por: Bernal-Bello, David, et al.
Publicado: (2020) -
Early clinical experience with imatinib in COVID-19: Searching for a dual effect
por: Morales-Ortega, Alejandro, et al.
Publicado: (2021) -
Optimism and caution for an inactivated COVID-19 vaccine
por: Rostad, Christina A, et al.
Publicado: (2021)